| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 12/22/2004 | CN1180793C Chinese medicine series for treating hepatitis A and B |
| 12/21/2004 | US6833373 Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 12/21/2004 | US6833364 Inhibiting degradation of cyclic guanosine monophosphate; cardiovascular disorders; such as 3-(4-amino-5-cyclopropyl-pyrimidin-2-yl)-1-(2-fluorobenzyl)1H-pyrazolo-(3,4 -b)-pyridine |
| 12/21/2004 | US6833362 Method and composition for the accelerated in vivo removal of ethanol |
| 12/21/2004 | US6833141 Method of treating pruritis and composition thereof |
| 12/21/2004 | CA2252071C Anti-caries oral compositions |
| 12/16/2004 | WO2004109390A1 Laser projector |
| 12/16/2004 | WO2004108153A1 Combined pharmaceutical preparations for the treatment of cancer, containing glutaminase and antineoplastic anthracyclines or platinum compounds |
| 12/16/2004 | WO2004108148A1 Processes for making caralluma extracts and uses |
| 12/16/2004 | WO2004108127A1 Nutritional composition and method of inhibiting smooth muscle cell contraction thereof |
| 12/16/2004 | WO2004108070A2 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 12/16/2004 | WO2004107881A1 Nutritional compositions and use thereof |
| 12/16/2004 | WO2004087212A3 Nitric oxide in treatment of inflammation |
| 12/16/2004 | US20040254092 Using mixture of ozone and perfluorohydrocarbon; liquid sterilization therapy |
| 12/16/2004 | US20040253323 An aqueous alkali metal salt solution contains cesium and rubidium salt of chloride, sulfate, carbonate, phosphate, lactate, citrate, and acetate; antitumor agents, antiproliferative agents; inhibiting secretion of tumor proteases, increase pH to neutralize acidic hypoxic cancerous neoplasms |
| 12/16/2004 | US20040253322 Mixtures of clinoptilolite, plant extracts and vitamins, used for attenuation of neuropathic pain associated with diabetes or prevent deposition of immunoglobulin on axons |
| 12/16/2004 | US20040253321 Bioactive glass comprising SiO2, Na2O, K2O, Li2O, CaO, MgO, Al2O3, P2O5, B2O3 and ZnO; free from silver, nontoxic; use in cosmetic, deodorants, medicinal products, paper hygiene |
| 12/16/2004 | US20040253320 A mixture of vitamins, minerals, simethicone for patients suffering inflammatory bowel disease; calcium carbonate, calcium sulphate; non-allergenic, improve absorption and side effect reduction |
| 12/16/2004 | US20040253319 Pharmaceutical compositions and method for alleviating side-effects of estrogen replacement therapy |
| 12/16/2004 | US20040253318 Preventing, alleviating symptoms of a skin condition with a complexes, such as lauryliminodipropionic acid tocopheryl phosphate; penetrating and absorption into skin; inflammation, erythema, wound, burn, dermatitis, gingivitis, sunburn, heat burn, psoriasis; cosmetics |
| 12/16/2004 | US20040253275 Pharmaceutical and cosmetic carrier or composition for topical application |
| 12/16/2004 | US20040253223 Treatment of aging disorders in humans |
| 12/16/2004 | US20040253213 Treatment of endothelin-related disorders |
| 12/16/2004 | US20040253201 Polyvalent metal-substituted starch products |
| 12/16/2004 | US20040253194 Pyrithione biocides enhanced by zinc metal ions and organic amines |
| 12/16/2004 | DE10323759A1 Heilmittel zur inneren Anwendung, insbesondere gegen Krebserkrankungen Remedies for internal use, especially against cancer |
| 12/16/2004 | DE10317922A1 Combination preparation for preventing reduced bone growth during intake of oral contraceptive, comprises oral contraceptive and calcium and vitamin D preparations |
| 12/16/2004 | CA2528897A1 Combined pharmaceutical preparations for the treatment of cancer, containing glutaminase and antineoplastic anthracyclines or platinum compounds |
| 12/16/2004 | CA2527702A1 Processes for making caralluma extracts and uses |
| 12/16/2004 | CA2526007A1 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 12/16/2004 | CA2524381A1 Nutritional composition and method of inhibiting smooth muscle cell contraction thereof |
| 12/15/2004 | EP1485413A2 Biologically active complex |
| 12/15/2004 | EP1485188A1 Portable oxygen concentrator |
| 12/15/2004 | EP1485145A1 Multiple compartment bag assembly for dialysis fluid |
| 12/15/2004 | EP1485095A1 Fluorinated 4-azasteroid derivatives as androgen receptor modulators |
| 12/15/2004 | EP1218005B1 Vitronectin receptor antagonists |
| 12/15/2004 | CN1555269A Exothermic formulations for the treatment of ectoparasites |
| 12/15/2004 | CN1555256A Pharmaceutical formulation comprising a proton pump inhibitor and antacids |
| 12/15/2004 | CN1554351A Medicinal composite preparation including active vitamine d compound and its use |
| 12/15/2004 | CN1554327A Plaster for promoting peristalsis and urination after operation |
| 12/15/2004 | CN1179744C Ointment having pain-killing relieving itching, removing toxic substances and promoting granulation function |
| 12/15/2004 | CN1179732C Medicine for curing beriberi and running sore and boil and its preparing method |
| 12/15/2004 | CN1179646C Aggregation-preventing nano broad spectrum antibacterial silver powder and its inductrial production process |
| 12/14/2004 | US6831286 Method for determining a tilt angle of an optical pickup head |
| 12/14/2004 | US6831103 Composition comprising theanine |
| 12/14/2004 | US6830754 Amphipatic lipid containing a hydroxy and amide group; and of a surfactant in an aqueous medium; a washing-away type cosmetic composition comprising the dispersion |
| 12/14/2004 | US6830753 Adsorbent for oral administration |
| 12/13/2004 | CA2432358A1 Nutritional supplementation for treating deficiency states in bowel disease |
| 12/09/2004 | WO2004105912A2 Method of producing eggshell powder |
| 12/09/2004 | WO2004105778A1 Combination consisting of a magnesium preparation having a prolonged release and of another active substance, and use thereof in the fields of cosmetics, therapeutics and/or nutrition |
| 12/09/2004 | WO2004105777A1 Rock flour, especially dolomite-based medicament, for the treatment of cancer diseases |
| 12/09/2004 | WO2004105761A1 Combined use of ecteinascidin-743 and platinum antineoplastic compounds |
| 12/09/2004 | WO2004105747A1 Combination chemotherapy comprising capecitabine and a liposomal platinum complex |
| 12/09/2004 | WO2004105744A1 Use of iron for treating attention deficit hyperactivity disorder in children |
| 12/09/2004 | WO2004105732A1 Combination chemotherapy comprising gemcitabine and a liposomal platinum complex |
| 12/09/2004 | WO2004105691A2 Pharmaceutical compositions for oral administration comprising lithium carbonate |
| 12/09/2004 | WO2004105682A2 Carbostyril derivatives and mood stabilizers for treating mood disorders |
| 12/09/2004 | WO2004080429A3 Use of thiol-based compositions in ameliorating mucosal injury |
| 12/09/2004 | WO2004045551A3 Pharmaceutical composition |
| 12/09/2004 | WO2003093478A9 Immunoconjugates for the treatment of tumours |
| 12/09/2004 | WO2003092468A3 Biomatrix structural containment and fixation systems and methods of use thereof |
| 12/09/2004 | US20040248873 Photoreactive compounds and compositions |
| 12/09/2004 | US20040248783 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 12/09/2004 | US20040247702 Caralluma extract products and processes for making the same |
| 12/09/2004 | US20040247697 Composition with dehydration preventive ingredients |
| 12/09/2004 | US20040247696 Administering at least one metal oxide compound having metal cation of first valance state and second metal oxide compound having metal cation of second valance state, other than first, for preventing, treating, or managing foot and mouth disease in an animal |
| 12/09/2004 | US20040247650 Zinc, copper, selenium or iron bound to or absorbed into the material matrix; wound healing agents; neovascularization; antiulcer agents; burn treatments before skin transplants; acute infections |
| 12/09/2004 | US20040247642 Instrument coated with magnesium-based compound for reducing thrombosis |
| 12/09/2004 | US20040247633 Novel dermatological composition |
| 12/09/2004 | US20040247535 Contains mono-, di- or tripotassium phosphate to inactivate dental nerves to relieve temporary pains; not only prevents but blocks the exposure of dentinal tubules; may also contain ursodesoxycholic acid and a humectant such as glycerin, sorbitol , xylitol, polyethylene glycol and/or propylene glycol |
| 12/09/2004 | US20040247532 NaCl, KCl, NaHCO3, monobasic or dibasic potassium phosphate saliva substitute; triclosan, chlorhexidine or benzalkonium and salts, or cetylpyridium chloride antiseptic; NaF, Na2PO3F, or xylitol anticariogenic agent; vitamin E acetate, panthenol, dipotassium glycyrrhizinate, or aloe vera extract |
| 12/09/2004 | DE102004002356A1 Verwendung von pulverförmigen Mischungen, enthaltend Wasserstoffperoxid und hydrophobiertes Siliciumdioxid zur kontrollierten Freisetzung von Wasserstoffperoxid oder Sauerstoff Use of pulverulent mixtures comprising hydrogen peroxide and hydrophobicized silica for controlled release of hydrogen peroxide or oxygen |
| 12/09/2004 | DE102004002355A1 Pulverförmiges Gemisch, enthaltend Wasserstoffperoxid und hydrophobiertes Siliciumdioxid Powdered mixture containing hydrogen peroxide and hydrophobized silica |
| 12/09/2004 | CA2527145A1 Use of iron for treating attention deficit hyperactivity disorder in children |
| 12/09/2004 | CA2526175A1 Medicament for internal application, in particular against cancerous diseases |
| 12/09/2004 | CA2525973A1 Combination chemotherapy comprising capecitabine and a liposomal platinum complex |
| 12/09/2004 | CA2525952A1 Combination chemotherapy comprising gemcitabine and a liposomal platinum complex |
| 12/09/2004 | CA2525908A1 Rock flour, especially dolomite-based medicament, for the treatment of cancer diseases |
| 12/09/2004 | CA2525887A1 Combined use of ecteinascidin-743 and platinum antineoplastic compounds |
| 12/08/2004 | EP1484086A2 Composition for preventing and curing the acne comprising zinc gluconate and copper gluconate |
| 12/08/2004 | EP1484065A1 Chinese preparation for treating enteritis ulcer colitis and preparation method thereof |
| 12/08/2004 | EP1483366A1 Antimicrobial composition |
| 12/08/2004 | EP1483290A2 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 12/08/2004 | EP1482988A1 METHOD OF RADIO−LABELLING BIOMOLECULES |
| 12/08/2004 | EP1482952A2 Therapeutic and prophylactic treatment of aging and disorders of aging in humans |
| 12/08/2004 | EP1439845A4 Inactivation of papillomavirus |
| 12/08/2004 | EP1035847A4 Stable solution of zinc and bicarbonate ions |
| 12/08/2004 | EP1027062B1 Germicidal compositions for the treatment of animal infectious diseases of the hoof, comprising a copper salt, a quaternary ammonium compound and a peroxide |
| 12/08/2004 | EP0801570B1 Formulations and methods for reducing skin irritation |
| 12/08/2004 | CN1553803A Use of 4-pyridylmethylphthalazines for cancer treatment |
| 12/08/2004 | CN1553795A Pharmaceutical and cosmetic compositions against skin aging |
| 12/08/2004 | CN1552348A Sedinafine composition and its use |
| 12/08/2004 | CN1552347A Far infrared thermal paste |
| 12/08/2004 | CN1552344A Alinate/alginic acid composition |
| 12/08/2004 | CN1178688C Health-care food for resisting fatigue |
| 12/08/2004 | CN1178687C Compound seabuckthorn fruit oil suppository |
| 12/08/2004 | CN1178669C Injection for treating pile and fistula and its preparing process |
| 12/08/2004 | CN1178642C Oral care compositions |
| 12/07/2004 | US6827932 Activated charcoal based composition and method for reducing hangover symptoms associated with the consumption of alcohol containing beverages |
| 12/02/2004 | WO2004104154A2 Pulverulent mixture comprising hydrogen peroxide and hydrophobized silicon dioxide |